Toxicology and Pharmacokinetics of DTGM, a Fusion Toxin Consisting of a Truncated Diphtheria Toxin (DT388) Linked to Human Granulocyte-Macrophage Colony-Stimulating Factor, in Cynomolgus Monkeys

This publication has 20 references indexed in Scilit:

• Cell-Specific Modulation of Drug Resistance in Acute Myeloid Leukemic Blasts by Diphtheria Fusion Toxin, DT388-GMCSF
  Bioconjugate Chemistry, 1998
• Toxicology and Pharmacokinetics of DT388-GM-CSF, a Fusion Toxin Consisting of a Truncated Diphtheria Toxin (DT388) Linked to Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in C57BL/6 Mice
  Toxicology and Applied Pharmacology, 1998
• Long-term survival in acute myeloid leukemia
  Cancer, 1997
• Therapy of Patients with T-cell Lymphomas and Leukemias Using an Anti-CD7 Monoclonal Antibody-Rich a Chain Immunotoxin
  Leukemia & Lymphoma, 1997
• A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells
  Blood, 1995
• Long-term persistence of anti-diphtheria toxin antibodies among adults in Israel
  European Journal of Epidemiology, 1994
• A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy
  Blood, 1993
• The crystal structure of diphtheria toxin
  Nature, 1992
• Regulation of surface expression of the granulocyte/macrophage colony-stimulating factor receptor in normal human myeloid cells.
  Proceedings of the National Academy of Sciences, 1990
• Phase I Study of an Anti-Breast Cancer Immunotoxin by Continuous Infusion: Report of a Targeted Toxic Effect Not Predicted by Animal Studies
  JNCI Journal of the National Cancer Institute, 1989